Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
A randomized controlled trial on the effect of behavioral strategies for adherence to oral antidiabetic drugs: study
Danilo D Trevisan1, Thaís M São-João1, Marilia E Cornélio1
1a School of Nursing , University of Campinas , Campinas , Brazil.
Background:
Non-adherence to oral antidiabetics drugs (OADs) has been a common problem and may contribute to poor glycemic control.
Aim:
To describe an experimental study protocol that aims at implementing and evaluating the effect of the "action planning and coping planning" interventions on medication adherence to OADs in patients with type 2 diabetes mellitus (T2DM) in follow-up at primary care services.
Design:
A randomized controlled trial.
Methods:
Two groups (intervention and control) will be followed over a period of 105 days. The intervention group will receive a combination of the "action planning" and "coping planning" intervention strategies. There will be in-person meetings and phone calls to reinforce the intervention. The control group will receive the usual care from the health unit.
Conclusions:
It is hoped that this study will help health professionals to improve their approach with patients who have T2DM in relation to medication adherence.
Related Concept Videos
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Oral Drug Delivery Systems: Introduction
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Oral Drug Delivery Systems: Continuous-Release Systems
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

